These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16182667)

  • 1. Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing.
    Dupuis A; Hamilton D; Cole DE; Corey M
    J Pediatr; 2005 Sep; 147(3):312-5. PubMed ID: 16182667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is cystic fibrosis carrier screening cost effective?
    Wei S; Quigg MH; Monaghan KG
    Community Genet; 2007; 10(2):103-9. PubMed ID: 17380060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot newborn screening project for cystic fibrosis in the Czech Republic: defining role of the delay in its symptomatic diagnosis and influence of ultrasound-based prenatal diagnosis on the incidence of the disease.
    Balascaková M; Holubová A; Skalická V; Zemková D; Kracmar P; Gonsorcíkova L; Camajová J; Piskácková T; Lebl J; Drevínek P; Gregor V; Vávrová V; Votava F; Macek M
    J Cyst Fibros; 2009 May; 8(3):224-7. PubMed ID: 19208501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFTR DeltaF508 mutation detection from dried blood samples in the first trimester of pregnancy: a possible routine prenatal screening strategy for cystic fibrosis?
    Konialis CP; Hagnefelt B; Kazamia C; Karapanou S; Pangalos C
    Fetal Diagn Ther; 2007; 22(1):41-4. PubMed ID: 17003555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-wide screening for cystic fibrosis carriers could replace newborn screening for the diagnosis of cystic fibrosis.
    Massie J; Forbes R; Dusart D; Bankier A; Delatycki MB
    J Paediatr Child Health; 2007 Nov; 43(11):721-3. PubMed ID: 17924936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
    Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
    Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic testing for cystic fibrosis. National Institutes of Health Consensus Development Conference Statement on genetic testing for cystic fibrosis.
    Arch Intern Med; 1999 Jul; 159(14):1529-39. PubMed ID: 10421275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased prevalence of chronic rhinosinusitis in carriers of a cystic fibrosis mutation.
    Wang X; Kim J; McWilliams R; Cutting GR
    Arch Otolaryngol Head Neck Surg; 2005 Mar; 131(3):237-40. PubMed ID: 15781764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The study of cystic fibrosis transmembrane conductance regulator gene mutations in a group of patients from Romania.
    Frenţescu L; Brownsell E; Hinks J; Malone G; Shaw H; Budişan L; Bulman M; Schwarz M; Pop L; Filip M; Tomescu E; Moşescu S; Popa I; Benga G
    J Cyst Fibros; 2008 Sep; 7(5):423-8. PubMed ID: 18467194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between carrier screening and incidence of cystic fibrosis.
    Castellani C; Picci L; Tamanini A; Girardi P; Rizzotti P; Assael BM
    JAMA; 2009 Dec; 302(23):2573-9. PubMed ID: 20009057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of intracytoplasmic sperm injection for a couple in which the man is carrier of CFTR p.[R74W;V201M;D1270N] and p.P841R mutations and his spouse a heterozygous carrier of p.F508del mutation of the cystic fibrosis transmembrane conductance regulator gene.
    Brugnon F; Bilan F; Heraud MC; Grizard G; Janny L; Creveaux I
    Fertil Steril; 2008 Nov; 90(5):2004.e23-6. PubMed ID: 18703181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier frequency of F508del mutation of cystic fibrosis in Indian population.
    Kapoor V; Shastri SS; Kabra M; Kabra SK; Ramachandran V; Arora S; Balakrishnan P; Deorari AK; Paul VK
    J Cyst Fibros; 2006 Jan; 5(1):43-6. PubMed ID: 16311077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of public health strategies on the birth prevalence of cystic fibrosis in Brittany, France.
    Scotet V; Audrézet MP; Roussey M; Rault G; Blayau M; De Braekeleer M; Férec C
    Hum Genet; 2003 Aug; 113(3):280-5. PubMed ID: 12768409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
    Sontag MK; Hammond KB; Zielenski J; Wagener JS; Accurso FJ
    J Pediatr; 2005 Sep; 147(3 Suppl):S83-8. PubMed ID: 16202790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.